ConCallIQ
Go Pro
Home › Apollo Hospitals Enterprise › Revenue History

Apollo Hospitals Enterprise Revenue History — Quarter by Quarter

Apollo Hospitals Enterprise's revenue moved from ₹4,418 Cr in Q1 FY24 to ₹6,477 Cr in Q3 FY26, a 46.6% change over 11 quarters. The table keeps each quarter linked back to the underlying earnings page.

Revenue by Quarter

QuarterRevenue (₹ Cr)YoY Change
Q3 FY26₹6,477 Cr+17%
Q2 FY26₹6,304 Cr+13%
Q1 FY26₹5,842 Cr+15%
Q4 FY25₹5,592 Cr+13%
Q3 FY25₹5,527 Cr+14%
Q2 FY25₹5,589 Cr+15%
Q1 FY25₹5,086 Cr+15%
Q4 FY24₹4,944 Cr+15%
Q3 FY24₹4,851 Cr+14%
Q2 FY24₹4,847 Cr+14%
Q1 FY24₹4,418 Cr+16%

What management said about revenue

G

Q3 FY26 · Digital business cash EBITDA breakeven delayed to Q1 FY27

Cash EBITDA breakeven for Apollo 24/7 pushed out by one quarter to Q1 FY27 due to insurance revenue recognition changes.

G

Q2 FY26 · Organic hospital growth to return to 13%

Management expects healthcare services organic growth to revert to 13% as Bangladesh patients return (60% already back in October) and new markets are explored.

G

Q2 FY26 · HealthCo margin target of 7% by Q4 FY27

Apollo HealthCo targeting INR 25,000 crore revenue run rate with 7% EBITDA margin by Q4 FY27, supported by KEIMED integration and digital break-even.

G

Q1 FY26 · Apollo 24/7 breakeven by Q4 FY26

Digital business expected to achieve EBITDA breakeven by end of fiscal year, with GMV run-rate of INR 800-900 crore.

G

Q1 FY26 · HealthCo+Keimed revenue run-rate of INR 25,000 crore by FY27

Combined entity targeting INR 25,000 crore revenue with 7% EBITDA margin by end of FY27.

G

Q4 FY25 · Healthcare services low-to-mid teens organic growth in FY26

Management expects organic revenue growth of low-to-mid teens for healthcare services in FY26, with new hospitals contributing from FY27.

G

Q4 FY25 · Digital business cash break-even by Q3-Q4 FY26

Apollo 24/7 is on track to achieve cash break-even between Q3 and Q4 of FY26, driven by cost reduction and revenue growth.

G

Q4 FY25 · HealthCo combined revenue target of INR 24,000-25,000 crore by FY27

Apollo HealthCo (including Keimed) targets revenue of INR 24,000 crore in FY27, with exit run rate crossing INR 25,000 crore.

G

Q3 FY25 · Apollo 24/7 break-even by Q2/Q3 FY26

Digital platform expected to achieve EBITDA break-even by end of Q2 or Q3 of next fiscal year, with GMV target of INR 900-1,000 crore.

G

Q3 FY25 · HealthCo revenue target of INR 25,000 crore by FY27

Apollo HealthCo (including Keimed) targets INR 25,000 crore revenue and 7-8% EBITDA margin by FY27.

G

Q2 FY25 · Apollo HealthCo online segment breakeven in 5-6 quarters

The online 24/7 platform is expected to achieve breakeven by Q2 FY26, with sustainable GMV growth and reduced marketing spend.

G

Q2 FY25 · Combined pharmacy revenue target of INR 25,000 crore in 3 years

Including Keimed, the pharmacy platform targets INR 25,000 crore revenue with 7-8% EBITDA margin.